FibroScan®
A novel noninvasive score including LSM by VCTE™ and routine clinical parameters improves the identification of cirrhosis among patients with MASLD and may reduce the necessity of liver biopsy in this patient population.
A novel noninvasive score including LSM by VCTE™ and routine clinical parameters improves the identification of cirrhosis among patients with MASLD and may reduce the necessity of liver biopsy in this patient population.